Citation Impact
31 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
Works of Nikolay Delev being referenced
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II , Randomized, Double‐Blind , Placebo‐Controlled Trial
2022 Standout
Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study
2022
Author Peers
| Author | Rheumatology | Immunology | Oncology | Hematology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Nikolay Delev | 275 | 227 | 67 | 98 | 24 | 381 | |
| Mahboubeh Tasviri | 2 | 26 | 486 | ||||
| Liang Dong | 5 | 51 | 30 | 4 | 18 | 316 | |
| Michael J. Colle | 1 | 26 | 315 | ||||
| Marc J. C. Scanio | 2 | 2 | 13 | 630 | |||
| Mel Campbell | 4 | 10 |
All Works
Loading papers...